Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Plos One|March 8, 2014
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysisRachel L O Donnell, Aiste McCormick, Asima Mukhopadhyay, et al.
Journal of Clinical Pathology|November 1, 1982
Use of monoclonal antibodies for the histopathological diagnosis of human malignancyK C Gatter, Z Abdulaziz, P Beverley, et al.
British Journal of Cancer|February 22, 2023
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcomeThomas D J Walker, Zahra F Faraahi, Marcus J Price, et al.
Journal of Clinical Pathology|April 29, 2005
Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ techniqueS G Jhavar, C Fisher, A Jackson, et al.
Nature Medicine|April 25, 2018
Understanding the tumor immune microenvironment (TIME) for effective therapyMikhail Binnewies, Edward W Roberts, Kelly Kersten, et al.
Oncotarget|October 22, 2020
Deconstructing tumor heterogeneity: the stromal perspectiveRenee E Vickman, Douglas V Faget, Philip Beachy, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Journal of Environmental Management|October 30, 2024
Using systems mapping to understand the constraints and enablers of solutions to plastic pollutionE K Morasae, Z L R Botterell, S H V Andrews, et al.
Cancer Discovery|June 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancerWilliam J McDaid, Helen Adderley, Paolo D d'Arienzo, et al.
Pageof 4